Quercetin Clinical Trials
8 recruitingDrug
Phase 24Phase 12Early Phase 11Not Applicable1
Showing 1–8 of 8 trials
Recruiting
Phase 1
Quercetin Dyskeratosis Congenita (DC)/Telomere Biology Disorders (TBD)
Dyskeratosis CongenitaTelomere Disease
Children's Hospital Medical Center, Cincinnati12 enrolled1 locationNCT07628972
Recruiting
Phase 1
Quercetin in Patients With XIAP (X-linked Inhibitor of Apoptosis) Deficiency
XIAP Deficiency
Children's Hospital Medical Center, Cincinnati12 enrolled1 locationNCT07433621
Recruiting
Not Applicable
Effects of Quercetin on Cardiometabolic Outcomes
Cardiometabolic Syndrome
University of Central Lancashire40 enrolled1 locationNCT06230861
Recruiting
Phase 2
Improving Physical Ability and Cellular Senescence Elimination in HIV
FrailtyHIVAging Problems+1 more
National Institute of Allergy and Infectious Diseases (NIAID)80 enrolled27 locationsNCT07144293
Recruiting
Phase 2
Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
Refractory Multiple MyelomaRecurrent Multiple Myeloma
Mayo Clinic44 enrolled1 locationNCT06940297
Recruiting
Early Phase 1
Sequential Treatments or Combinations Including Dasatinib, Quercetin, Fisetin and/or Temozolomide for the Treatment of Previously Treated Glioma With Residual Disease
Glioma
Mayo Clinic10 enrolled1 locationNCT07025226
Recruiting
Phase 2
Effects of Adding Quercetin or Alpha Lipoic Acid to Usual Care on Symptoms and Blood Markers in Iraqi Women With Polycystic Ovary Syndrome
PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
Al-Mustansiriyah University150 enrolled1 locationNCT07182526
Recruiting
Phase 2
Dasatinib Combined With Quercetin to Reverse Chemo Resistance in Triple Negative Breast Cancer
Triple-Negative Breast Cancer
Fudan University10 enrolled1 locationNCT06355037